308 related articles for article (PubMed ID: 25381821)
21. Down-regulation of wild-type p53-induced phosphatase 1 (Wip1) plays a critical role in regulating several p53-dependent functions in premature senescent tumor cells.
Crescenzi E; Raia Z; Pacifico F; Mellone S; Moscato F; Palumbo G; Leonardi A
J Biol Chem; 2013 Jun; 288(23):16212-16224. PubMed ID: 23612976
[TBL] [Abstract][Full Text] [Related]
22. Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase.
Fujimoto H; Onishi N; Kato N; Takekawa M; Xu XZ; Kosugi A; Kondo T; Imamura M; Oishi I; Yoda A; Minami Y
Cell Death Differ; 2006 Jul; 13(7):1170-80. PubMed ID: 16311512
[TBL] [Abstract][Full Text] [Related]
23. WIP1 phosphatase modulates the Hedgehog signaling by enhancing GLI1 function.
Pandolfi S; Montagnani V; Penachioni JY; Vinci MC; Olivito B; Borgognoni L; Stecca B
Oncogene; 2013 Oct; 32(40):4737-47. PubMed ID: 23146903
[TBL] [Abstract][Full Text] [Related]
24. Wiping DNA methylation: Wip1 regulates genomic fluidity on cancer.
Muñoz-Lopez M; Medina PP; Garcia-Perez JL
Cancer Cell; 2013 Oct; 24(4):405-7. PubMed ID: 24135277
[TBL] [Abstract][Full Text] [Related]
25. Timely Degradation of Wip1 Phosphatase by APC/C Activator Protein Cdh1 is Necessary for Normal Mitotic Progression.
Jeong HC; Gil NY; Lee HS; Cho SJ; Kim K; Chun KH; Cho H; Cha HJ
J Cell Biochem; 2015 Aug; 116(8):1602-12. PubMed ID: 25649870
[TBL] [Abstract][Full Text] [Related]
26. The Wip1 phosphatase PPM1D dephosphorylates SQ/TQ motifs in checkpoint substrates phosphorylated by PI3K-like kinases.
Yamaguchi H; Durell SR; Chatterjee DK; Anderson CW; Appella E
Biochemistry; 2007 Nov; 46(44):12594-603. PubMed ID: 17939684
[TBL] [Abstract][Full Text] [Related]
27. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
[TBL] [Abstract][Full Text] [Related]
28. WIP1 stimulates migration and invasion of salivary adenoid cystic carcinoma by inducing MMP-9 and VEGF-C.
Tang YL; Liu X; Gao SY; Feng H; Jiang YP; Wang SS; Yang J; Jiang J; Ma XR; Tang YJ; Chen Y; Liang XH
Oncotarget; 2015 Apr; 6(11):9031-44. PubMed ID: 25797250
[TBL] [Abstract][Full Text] [Related]
29. Chemical inhibition of Wip1 phosphatase contributes to suppression of tumorigenesis.
Belova GI; Demidov ON; Fornace AJ; Bulavin DV
Cancer Biol Ther; 2005 Oct; 4(10):1154-8. PubMed ID: 16258255
[TBL] [Abstract][Full Text] [Related]
30. Development of a substrate-based cyclic phosphopeptide inhibitor of protein phosphatase 2Cdelta, Wip1.
Yamaguchi H; Durell SR; Feng H; Bai Y; Anderson CW; Appella E
Biochemistry; 2006 Nov; 45(44):13193-202. PubMed ID: 17073441
[TBL] [Abstract][Full Text] [Related]
31. Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D.
Castellino RC; De Bortoli M; Lu X; Moon SH; Nguyen TA; Shepard MA; Rao PH; Donehower LA; Kim JY
J Neurooncol; 2008 Feb; 86(3):245-56. PubMed ID: 17932621
[TBL] [Abstract][Full Text] [Related]
32. The structure and expression of the murine wildtype p53-induced phosphatase 1 (Wip1) gene.
Choi J; Appella E; Donehower LA
Genomics; 2000 Mar; 64(3):298-306. PubMed ID: 10756097
[TBL] [Abstract][Full Text] [Related]
33. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
[TBL] [Abstract][Full Text] [Related]
34. Wip1 deficiency impairs haematopoietic stem cell function via p53 and mTORC1 pathways.
Chen Z; Yi W; Morita Y; Wang H; Cong Y; Liu JP; Xiao Z; Rudolph KL; Cheng T; Ju Z
Nat Commun; 2015 Apr; 6():6808. PubMed ID: 25879755
[TBL] [Abstract][Full Text] [Related]
35. Wip1 suppresses apoptotic cell death through direct dephosphorylation of BAX in response to γ-radiation.
Song JY; Ryu SH; Cho YM; Kim YS; Lee BM; Lee SW; Choi J
Cell Death Dis; 2013 Aug; 4(8):e744. PubMed ID: 23907458
[TBL] [Abstract][Full Text] [Related]
36. Dose-dependent mutual regulation between Wip1 and p53 following UVC irradiation.
Xia Y; Yang Q; Gong X; Ye F; Liou YC
Int J Biochem Cell Biol; 2011 Apr; 43(4):535-44. PubMed ID: 21163364
[TBL] [Abstract][Full Text] [Related]
37. WIP1 phosphatase as pharmacological target in cancer therapy.
Pecháčková S; Burdová K; Macurek L
J Mol Med (Berl); 2017 Jun; 95(6):589-599. PubMed ID: 28439615
[TBL] [Abstract][Full Text] [Related]
38. The role of PPM1D in cancer and advances in studies of its inhibitors.
Deng W; Li J; Dorrah K; Jimenez-Tapia D; Arriaga B; Hao Q; Cao W; Gao Z; Vadgama J; Wu Y
Biomed Pharmacother; 2020 May; 125():109956. PubMed ID: 32006900
[TBL] [Abstract][Full Text] [Related]
39. Involvement of dysregulated Wip1 in manganese-induced p53 signaling and neuronal apoptosis.
Ma X; Han J; Wu Q; Liu H; Shi S; Wang C; Wang Y; Xiao J; Zhao J; Jiang J; Wan C
Toxicol Lett; 2015 May; 235(1):17-27. PubMed ID: 25791630
[TBL] [Abstract][Full Text] [Related]
40. Off-target response of a Wip1 chemical inhibitor in skin keratinocytes.
Lee JS; Park JR; Kwon OS; Kim H; Fornace AJ; Cha HJ
J Dermatol Sci; 2014 Feb; 73(2):125-34. PubMed ID: 24126074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
